Previously primed and activated tumor-infiltrating CD8+ cytotoxic T cells bind with their T cell receptor (TCR) to the cognate antigen, which is presented on the surface of cancer cells via MHC I molecules (Fig. 1(5)) [19]. This evidence concerns the gene CD8A and neoplasm.